Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder

Investigative and Clinical Urology

Ghee Young Kwon¹  Won Park²  Chan Kyo Kim³  Hyun Hwan Sung⁴  Wan Song⁴  Byong Chang Jeong⁴  Se Hoon Park⁵  Hana Kim⁵  Ryul Kim⁵ 

[1] Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.;Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.;Department of Radiology and Center for Imaging Sciences, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.;Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.;Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.;

关键词: bladder cancer;    concurrent chemoradiotherapy;    neoadjuvant chemotherapy;   

DOI  :  10.4111/icu.20210407

来源: DOAJ

【 授权许可】

Unknown